Precision Neuroscience

Series-B+
precisionneuro.io Biotech & Healthcare Manhattan, United States Founded 2021 101-250
Total Funding $303M
Latest Round $250M Series-B+
Last Announced Sep 24, 2026
Investors 23 Backers
Decision Makers 6 Verified

About Precision Neuroscience

Precision Neuroscience develops brain-computer interface technology. This technology helps people with paralysis operate digital devices using their thoughts. The system uses a cortical interface to record brain signals and supports applications in healthcare.

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry Biotech & Healthcare
Funding Stage Series-B+
Global Headquarters Manhattan, United States
Year Founded 2021
Team Size 101-250
Tracked Since Oct 9, 2026

Web & Domain Identity

Official Website precisionneuro.io
Domain Registered Date Jan 25, 2021

Social & Network Presence

X / Twitter Profile @PrecisionNeuro_ (1.2K followers) Created on Jan 2024
LinkedIn Corporate Company Profile

Company Milestones & Timeline

7 Events
  1. Capital Raise

    Raised $250,000,000 · Series-B

    Backed by Pershing Square Inc., ARK Investment Management

  2. Capital Raise

    Series-B announced

    Backed by General Equity Holdings, Forepont Capital Partners

  3. Milestone

    X account created (@PrecisionNeuro_)

    1.2K followers

  4. Capital Raise

    Raised $41,000,000 · Series-B

    Backed by Forepont Capital Partners, Alumni Ventures

  5. Capital Raise

    Raised $12,000,000 · Series-A

    Backed by B Capital, Steadview Capital

  6. Milestone

    Website domain registered

    precisionneuro.io

  7. Milestone

    Company founded

    Manhattan, United States

Investors & Backers

23
Ackman Oxman Institute
Alumni Ventures
ARK Investment Management
B Capital
Draper Associates
Duquesne Family Office
Forepont Capital Partners
General Equity Holdings
Hitachi Ventures
Invus
JSL Health Capital
Korea Investment Partners
Korean Investment Partners
Mirae Asset Capital
mobihealthnews.com
Mubadala Capital Ventures
Pershing Square Inc.
Protocol Labs
re.Mind Capital
Riverhorse Investments
SCI Ventures
Soleus Capital
Steadview Capital

Funding History

4 Rounds
Series-B equity · Sep 24, 2026

Round backers: Pershing Square Inc., ARK Investment Management, B Capital, Duquesne Family Office, Hitachi Ventures, Invus, JSL Health Capital, Korea Investment Partners, Mirae Asset Capital, Mubadala Capital Ventures

$250,000,000 globenewswire.com
Series-B equity · Nov 11, 2024

Round backers: General Equity Holdings, Forepont Capital Partners, JSL Health Capital, Korean Investment Partners, Mubadala Capital Ventures, Protocol Labs, Riverhorse Investments, SCI Ventures, Soleus Capital, Steadview Capital, mobihealthnews.com

Undisclosed
Series-B equity · Jan 25, 2023

Round backers: Forepont Capital Partners, Alumni Ventures, B Capital, Draper Associates, Mubadala Capital Ventures, re.Mind Capital, Steadview Capital

$41,000,000 biospace.com
Series-A equity · May 25, 2021

Round backers: B Capital, Steadview Capital, Forepont Capital Partners

$12,000,000 prnewswire.com

Founders & Leadership

9

Benjamin Rapoport

Founder

Work email & phone locked Unlock →

Demetrios Papageorgiou

Founder

Work email & phone locked Unlock →

Jayme Strauss

Chief Clinical Officer

Work email & phone locked Unlock →

Joel Greengrass

Chief People Officer

Work email & phone locked Unlock →

John Woock

Chief Business Officer

Work email & phone locked Unlock →

Mark Hettick

Founder

Work email & phone locked Unlock →

Michael Kaswan

Chief Financial Officer

Work email & phone locked Unlock →

Michael Mager

Founder

Work email & phone locked Unlock →

Nathan Pletcher

Chief Technology Officer

Work email & phone locked Unlock →

Press Coverage & Sources

Recently Funded Biotech & Healthcare Startups

View all

Search the startup feeds free with 50 starter credits.

START FREE WITH 50 CREDITS
Recently funded startups
New SaaS launches
Never pay twice for contacts